Policlinico Universitario Campus Biomedico

Rome 00128

1 studies enrolling now · 6 studies all time

What they study most

Advanced Renal Cell Carcinoma, Autosomal Dominant Hypocalcemia, Melanoma, Melanoma Stage III, Melanoma Stage IV, Metastatic Renal Cell Carcinoma, Ulcerative Colitis, Ulcerative Colitis Chronic, Unresectable Melanoma

Studies at this site

• A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis — Recruiting now
• ADH1 and ADH2 Disease Monitoring Study (DMS) — Running, not enrolling
• Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma — Completed
• A Study to Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment — Completed
• The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis — Stopped early
• CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma — Completed